Public Health England have updated their analysis of Variants of Concern and Variants under Investigation. It is great that this expert analysis has been published.
Some commentary.
Firstly, the India variant (B.1.617). This has been split. Only B.1.617.1 with E484Q is a Variant under Investigation.
Variants of Concern remain
B.1.1.7 (UK/Kent)
B.1.351 (South Africa)
P.1 (Manaus)
B.1.1.7 with E484K
Several other variants are being monitored.
This is PHE's chart of variant prevalence. As you can see, B.1.1.7 (Kent variant) dominates (purple)
Excluding B.1.1.7 (Kent variant) you can see that there are a range of variants detected since January
B.1.351 (South Africa) in blue
B.1.617.1 with E484Q (India, variant under investigation, a sub-category of B.1.617) in green
The scale goes up to 0.015 or 1.5% of sequences
This is where the India variant under investigation has been found in England.
Some regions have 100% of cases where they have been from travellers.
Here are the India variant under investigation cases on a map
And ages and sex of those detected India variant under investigation cases
Most are from travellers, some are contacts of travellers, 3 are not travel-associated
These are the deaths associated with variants of concern and variants under investigation. Note no deaths reported as at 22 April 2021 for the India variant.
Note case fataility rate for VUI-21FEB-03 though. But there are wide confidence intervals for all these.
These are the *modelled* growth rates relative to a B.1.1.7 (Kent) baseline.
These are the Seconary Attack Rates
This is the spatial risk
Finally, on to the *risk assessment* for these variants
VOC-20DEC-01 (B.1.1.7)
High risk, but we knew that - that's why we had Lockdown 3 - the Kent/UK variant.
Risk assessments appear to be ongoing for the B.1.617 (India) variant.
So, in summary
- Yes, we have the India variant
- Vast majority of cases are from travellers
- Risk assessment is ongoing
"Numbers of all variants under investigation remain low"
Finally, @PHE_uk is full of experts, calling on expertise from virologists, immunologists, and many others.
Immunology and virology are *very tricky* and, as with science generally, rigorous, methodical investigation is required to produce robust analysis.
Many thanks.
Here are my charts of cases from data published earlier today
Oh, and for anyone that's confused between the *many* ways that the variants are described (and that's most of us), here's a handy table I made cross-referencing the different ways the Variants of Concern and Variants under Investigation are known.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
The latest @PHE_UK variant data has been published for the UK. First, the heatmap of new cases.
Significantly:
P1 (Manaus) has increased from 40 to 60 total cases
B.1.617 (India) has increased from 77 to 132 total cases.
B.1.351 (SA) has increased from 600 to 670 total cases
Here is my Covid variants cumulative chart (excluding UK variant).
Here are my heatmaps for detected cases, hospitalizations, vaccines, and variants. Data released 22 April 2021 for cases to 18 April 2021 apart from variants (data to 21 April 2021).
DETECTED CASES
Falling in all age groups. A very good sign. Cases will not yet have been detected as a result of Step 2 (open air pubs etc.)
Vaccination progress is excellent - but it's worth noting there are disparities. It was good to hear in yesterday's Number 10 press conference that some of these disparities are being reduced.
Let's look at the most recent data (published 14 April, for vaccinations to 7 April)
The first disparity is age. But this is due to prioritization based on risk and makes sense.
Here are my updated charts which now highlight the B.1.617 Variant under Investigation (first detected in India) in blue
You can see the 77 cases reported this week as the light blue line
It is not clear from this 'initial report' whether all these cases were detected this week
Here's the same data on a logarithmic scale including B.1.1.7 (Kent)
It is clear that the number of B.1.617 (Variant under Investigation) first detected in India) is of significance.
Further work will be going on by experts at @PHE_uk to determine how significant.
The Roadmap fourth test that 'our assessment of the risks is not fundamentally changed by new Variants of Concern'.
It is worth remembering that even though the vaccination rollout is going extremely well, not everyone is vaccinated and vaccines are not 100% effective.
"In England, ... 54.9% of the population (95% credible interval: 49.5% to 60.0%) would have tested positive for antibodies against the coronavirus (COVID-19)... on a blood test in the week ending 28 March 2021, suggesting they had the infection in the past or have been vaccinated
Imporant caveat:
"Across all four countries of the UK, there is a clear pattern between vaccination and testing positive for COVID-19 antibodies **but the detection of antibodies alone is not a precise measure of the immunity protection given by vaccination**.